2024 Global Thyroid Cancer Diagnostics Market Report: Key Drivers, Size, and Leading Segments
Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What Growth Rate is Predicted for the Thyroid Cancer Diagnostics Market for 2024-2033?
In recent times, the market size for thyroid cancer diagnostics has witnessed robust growth. It is anticipated to expand from $2.79 billion in 2023 to $2.97 billion in 2024 with a compound annual growth rate (CAGR) of 6.2%. Numerous factors contributed to this growth in the past such as increasing instances of thyroid cancer, ageing population, heightened awareness and early detection, governmental aid and initiatives, and enhanced healthcare infrastructure.
In the coming years, the thyroid cancer diagnostics market is projected to experience substantial growth, escalating to $3.7 billion in 2028 with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth during the forecast period include increasing demand for companion diagnostic procedures, a rising trend towards personalized medicine among patients, economic development and healthcare expenditure, education and training of physicians, and regulatory approvals and clearances. Key trends expected in this period encompass liquid biopsies, adoption of diagnostic technologies globally, technological progress, research and development initiatives, incorporation of artificial intelligence, and collaboration and partnership strategies.
Claim Your Free Sample of the Global Thyroid Cancer Diagnostics Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12030&type=smp
What Drivers Are Enhancing the thyroid cancer diagnostics Market’s Growth?
The growth of the thyroid cancer diagnostic market is being propelled by the rising incidence of thyroid cancer. Thyroid cancer is a condition that affects the thyroid gland, a gland responsible for producing hormones that regulate body temperature, heart rate, blood pressure, and weight. Diagnostic tools for thyroid cancer facilitate early detection of the disease, improving treatment outcomes. Consequently, the growing incidence of thyroid cancer drives the demand for the diagnostic market. For example, in September 2023, a report from the American Cancer Society, a US-based non-profit organization, predicts about 43,720 new instances of thyroid cancer, with 12,540 in men and 31,180 in women. The forecasted number of thyroid cancer-related deaths in the same year stands at around 2,120, comprising 970 men and 1,150 women. Hence, the escalating incidence of thyroid cancer fuels the thyroid cancer diagnostic market’s growth.
What Segments Are Central to the Thyroid Cancer Diagnostics Market?
1) By Technique Type: Imaging Test, Blood Test, Biopsy, Other Test Type
2) By Disease Type: Papillary Carcinoma, Follicular Carcinoma, Other Diseases
3) By End-User: Hospital Laboratories, Cancer Diagnostic Centers, Research Institutes, Other End-Users
What Emerging Trends Are Influencing Thyroid Cancer Diagnostics Industry Dynamics?
Key players in the thyroid cancer diagnostic market are focusing on creating groundbreaking products like oral tablets, to engage a wider customer demographic, boost sales and elevate revenue. Oral tablets are a form of solid medicament designated for oral intake. For example, in September 2021, Exelixis Inc., an American biotech firm, publicized the authorization of CABOMETYX (cabozantinib) by the U.S. Food and Drug Administration (FDA). This solution is reserved for treating differentiated thyroid cancer (DTC) in adults and children aged 12 and over who suffer from locally advanced or metastatic illness. This approach is meant exclusively for cases that have progressed post prior vascular endothelial growth factor receptor (VEGFR)-targeted therapy and patients who are either resistant to radioactive iodine or disqualified from such therapy. CABOMETYX tablets have been awarded approval for numerous applications, including the treatment of advanced renal cell carcinoma (RCC), hepatocellular carcinoma in patients who received prior treatment with sorafenib, first-line therapy for advanced RCC in alliance with nivolumab, and the control of locally advanced or metastatic differentiated thyroid cancer (DTC) in adult and pediatric patients aged 12 and up.
Order Now for Fast Delivery of Your Thyroid Cancer Diagnostics Market Report!
https://www.thebusinessresearchcompany.com/report/thyroid-cancer-diagnostics-global-market-report
Which Geographic Locations Are Critical to the Growth of the Thyroid Cancer Diagnostics Market?
North America was the largest region in the thyroid cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The Thyroid Cancer Diagnostics Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the thyroid cancer diagnostics market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Thyroid Cancer Diagnostics Market Include
1. Thyroid Cancer Diagnostics Market Executive Summary
2. Thyroid Cancer Diagnostics Market Segments
3. Thyroid Cancer Diagnostics Market Size And Template Market Growth Rate
4. Key Thyroid Cancer Diagnostics Market Trends
5. Major Thyroid Cancer Diagnostics Market Drivers
……
25. Key Mergers And Acquisitions In The Thyroid Cancer Diagnostics Market
26. Top Thyroid Cancer Diagnostics Companies
27. Thyroid Cancer Diagnostics Market Opportunities And Strategies
28. Thyroid Cancer Diagnostics Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Cancer biologics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/cancer-biologics-global-market-report
Breast Cancer Monoclonal Antibodies Global Market Report 2024
Colorectal Cancer Drugs Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/colorectal-cancer-drugs-global-market-report
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
